Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments

被引:2
|
作者
Poiseuil, Marie [1 ,6 ]
Moutel, Gregoire [2 ,3 ]
Cosson, Mathilde [4 ]
Quertier, Marie-Christine [5 ]
Duchange, Nathalie [2 ]
Darquy, Sylviane [1 ]
机构
[1] Bordeaux Univ, Inserm U1219, EPICENE, Canc & Exposit Environm, Bordeaux, France
[2] Unicaen, Normandy Univ, ANTICIPE, INSERM U1086, Caen, France
[3] Univ Normandie, Espace Reg Reflex Eth, CHU Caen, Caen, France
[4] Ctr Reg Coordinat Depistage Canc CRCDC, Bretagne, France
[5] Ctr Reg Coordinat Depistage Canc CRCDC, Normandie, France
[6] Univ Bordeaux, Res Ctr U1219, Equipe EPICENE, Inserm,Bordeaux Populat Hlth, 146 rue Leo Saignat, F-33076 Bordeaux, France
关键词
breast cancer; cancer screening; women's attendance; questionnaire; HEALTH-CARE; BARRIERS; REASONS; FRANCE;
D O I
10.1097/CEJ.0000000000000777
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundToday, women 50 years of age are offered three types of cancer screening in France. However, participation is not optimal. The aim was to describe (1) participation in organised breast cancer screening (OS) of women aged 56 years old, and the influence of this participation on colorectal and cervical cancer screening, (2) the reasons for non-participation in breast cancer OS, and (3) the reasons for screening before age 50. MethodsA questionnaire was sent to 56-year-old women in four French departments to identify their participation behaviour in three breast cancer OS invitations and their reasons for non-participation. Three groups were determined according to the number of participations in breast cancer OS (3, 1-2 and 0). We described the quantitative responses and grouped the qualitative responses thematically. ResultsA total of 4634 women responded to the questionnaire. Seventy-six percent had undergone all three breast cancer OS, 16% irregular and 7% non-participant. Among women who irregularly perform breast cancer OS, 50.5% also irregularly perform colorectal cancer OS. Women who participated in all three invitations for the breast cancer OS performed more smear tests than women in the other groups. Many of the irregular participants or non-participants underwent opportunistic screening, often initiated before the age of 50. The reasons for non-participation in breast cancer OS were mainly medical or participation in opportunistic screening. ConclusionThere is no fundamental opposition to participation in breast cancer screening. However, it remains of the utmost importance that women should be better informed about OS and its benefits.
引用
收藏
页码:238 / 245
页数:8
相关论文
共 50 条
  • [21] Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer
    Klarenbach, Scott
    Sims-Jones, Nicki
    Lewin, Gabriela
    Singh, Harminder
    Theriault, Guylene
    Tonelli, Marcello
    Doull, Marion
    Courage, Susan
    Garcia, Alejandra Jaramillo
    Thombs, Brett D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (49) : E1441 - E1451
  • [22] Randomized Trial of Information for Older Women About Cessation of Breast Cancer Screening Invitations
    Smith, Jenna
    Cvejic, Erin
    Houssami, Nehmat
    Schonberg, Mara A.
    Vincent, Wendy
    Naganathan, Vasi
    Jansen, Jesse
    Dodd, Rachael H.
    Wallis, Katharine
    Mccaffery, Kirsten J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (08) : 1332 - 1341
  • [23] Participation in Mammography Screening and quality of life in women with breast cancer
    Braun, B.
    Khil, L.
    Tio, J.
    Krause-Bergmann, B.
    Fuhs, A.
    Heidinger, O.
    Hense, H. -W.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 147 - 147
  • [24] Breast cancer screening for women aged 40-49 years: Screening may not be the benign process usually thought
    Retsky, M
    Demicheli, R
    Hrushesky, W
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (20): : 1572 - 1572
  • [25] Trusting technology: Women aged 40-49 years participating in screening for breast cancer - an exploratory study
    Willis, K
    Baxter, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2003, 27 (03) : 282 - 286
  • [26] ATTITUDE TOWARDS PARTICIPATION ON BREAST CANCER SCREENING AND THE ASSESSMENT OF INFLUENCING FACTORS AMONG 45-65 YEARS OLD WOMEN
    Mate, Z.
    Vajda, R.
    Kives, Z.
    Olah, A.
    Csakvari, T.
    Karacsony, I
    Boncz, I
    Pakai, A.
    VALUE IN HEALTH, 2019, 22 : S525 - S525
  • [27] Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes
    Trentham-Dietz, Amy
    Kerlikowske, Karla
    Stout, Natasha K.
    Miglioretti, Diana L.
    Schechter, Clyde B.
    Ergun, Mehmet Ali
    van den Broek, Jeroen J.
    Alagoz, Oguzhan
    Sprague, Brian L.
    van Ravesteyn, Nicolien T.
    Near, Aimee M.
    Gangnon, Ronald E.
    Hampton, John M.
    Chandler, Young
    de Koning, Harry J.
    Mandelblatt, Jeanne S.
    Tosteson, Anna N. A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 700 - +
  • [28] Breast Cancer Screening Rates Among Women Aged 20 Years and Above - China, 2015
    Zhang, Mei
    Zhong, Yijing
    Bao, Heling
    Zhao, Zhenping
    Huang, Zhengjing
    Zhang, Xiao
    Li, Chun
    Zhou, Maigeng
    Wang, Limin
    Wu, Jing
    Zheng, Xiaoying
    Wang, Linhong
    CHINA CDC WEEKLY, 2021, 3 (13): : 267 - 273
  • [29] Breast cancer screening motivation and behaviours of women aged over 75 years: a scoping review
    Dickson-Swift, Virginia
    Adams, Joanne
    Spelten, Evelien
    Blackberry, Irene
    Wilson, Carlene
    Yuen, Eva
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [30] Screening mammography for women with a family history of breast cancer -: Response of the French National Technical Group for Breast Cancer Screening
    Eisinger, F
    Bressac, B
    Castaigne, D
    Cottu, PH
    Lansac, J
    Lefranc, JP
    Lesur, A
    Noguès, C
    Pierret, J
    Puy-Pernias, S
    Sobol, H
    Tardivon, A
    Tristant, H
    Villet, R
    BULLETIN DU CANCER, 2004, 91 (7-8) : 656 - 656